Supreme Court: Award Valid Even If Passed After Mandate Expiry When Court Extends Time  ||  Jharkhand HC: Regular Bail Plea During Interim Bail is Not Maintainable under Section 483 BNSS  ||  Cal HC: Theft Claims and Public Humiliation Alone Don’t Amount To Abetment of Suicide U/S 306 IPC  ||  Delhi High Court: Elective Surgery Does Not Bar Grant of Interim Bail on Medical Grounds  ||  Delhi HC: Consensual Romance With Minor Nearing 18 May be Considered For Bail in POCSO Case  ||  Delhi HC: Not Named In FIR Doesn’t Matter If Financial Links Show Active Role in NDPS Offence  ||  Chhattisgarh HC: Rape is an Affront to Womanhood and a Brutal Violation of The Right To Life  ||  Supreme Court: Single Insolvency Petition Maintainable Against Linked Corporate Entities  ||  Supreme Court: Disputes are Not Arbitrable When the Arbitration Agreement is Alleged to be Forged  ||  Supreme Court: Temple Trust Does Not Qualify as an ‘Industry’ under the Industrial Disputes Act    

Delhi HC Seeks Centre's Response on How It Intends to Obtain Supply of Tocilizumab Drug - (17 May 2021)

CIVIL

Delhi High Court has sought Centre's response on the demand of Tocilizumab drug and how does the Centre intend to obtain the supplies of the said drug through Roche India and other global manufacturers, observing that no assurance was given by Roche India, which enjoys the license of manufacturing Tocilizumab 400 mg, if any further stock can be supplied to India.

Tags : DELHI HIGH COURT   SUPPLY OF TOCILIZUMAB DRUG  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved